Aclaris Therapeutics ACRS Balance Sheet (2014-2026)

NASDAQ ACRS
$6.11 +0.16 (+2.61%)
As of: Sep 4, 2026 · 12:49 PM EDT
Reported Financials

Aclaris Therapeutics Quarterly Balance Sheet

Periods 48 quarters
Latest Jun 2026

Aclaris Therapeutics reported total assets of $179.69M and total liabilities of $55.11M for the quarter ended Jun 2026, down 5.0% year over year. This balance sheet covers 48 quarters of results from Sep 2014 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Balance Sheet Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Accumulated Depreciation
3.21M3.39M3.54M3.70M3.87M4.04M4.21M4.41M4.60M4.16M4.34M4.52M4.68M4.80M4.91M5.01M4.98M
Assets
Current Assets
Cash & EquivalentsCash & Equiv.
53.60M27.35M36.34M68.26M61.65M45.28M44.72M31.15M39.04M39.88M35.84M22.83M47.65M24.57M30.36M25.40M25.26M19.96M28.66M19.17M
Receivables - NetNet Receivables
0.81M0.62M0.63M0.64M0.60M0.48M0.69M0.43M0.35M0.30M0.37M0.33M0.34M0.32M0.25M0.19M
Receivables - OtherOther Receivables
0.02M0.02M
Receivables
0.83M0.65M0.63M0.64M0.60M0.48M0.69M0.43M0.35M0.30M0.37M0.33M0.34M0.32M0.25M0.19M
Inventory
Prepaid Assets
7.09M12.99M10.63M10.11M7.91M13.49M12.87M12.73M19.67M9.45M6.80M6.22M4.26M12.04M3.23M4.20M
Current Assets
205.78M205.03M190.88M259.35M256.57M231.55M184.36M132.94M123.07M128.86M135.34M117.64M132.33M125.95M108.79M104.20M100.59M96.32M110.23M97.77M
Non-Current Assets
Property, Plant & Equipment (Net)
1.17M1.33M1.28M1.28M1.15M1.10M1.51M1.90M1.76M1.62M1.53M1.29M1.13M1.01M0.94M0.87M0.81M0.76M0.75M0.66M
Long-Term Investments
45.73M34.24M23.95M7.22M12.24M33.60M90.99M83.94M62.77M33.20M38.78M45.71M90.30M85.21M81.08M71.30M60.61M85.37M79.06M
Goodwill
Intangibles
7.38M7.38M7.38M7.01M6.99M7.38M7.38M7.38M7.38M0.75M
Goodwill & Intangibles
7.38M7.38M7.38M7.01M6.99M7.38M7.38M7.38M7.38M0.75M
Other Non-Current Assets
3.74M3.55M3.38M3.11M2.92M2.73M3.27M2.89M2.66M4.16M4.00M3.37M3.22M3.07M3.15M2.99M2.83M2.77M2.37M2.20M
Non-Current Assets
57.71M46.18M35.65M18.62M11.06M23.05M45.34M102.71M95.29M68.55M38.73M43.44M50.06M94.38M89.30M84.94M74.94M64.14M88.49M81.93M
Assets
263.49M251.21M226.53M277.98M267.63M254.60M229.71M235.65M218.35M197.41M174.06M161.07M182.39M220.33M198.09M189.15M175.53M160.46M198.72M179.69M
Liabilities
Current Liabilities
Accounts Payables
7.56M9.98M8.12M5.70M7.67M10.35M8.19M11.43M9.65M8.88M10.81M7.27M7.66M4.69M6.35M8.80M9.19M13.16M14.73M15.52M
Notes Payables
Payables
7.56M9.98M8.12M5.70M7.67M10.35M8.19M11.43M9.65M8.88M10.81M7.27M7.66M4.69M6.35M8.80M9.19M13.16M14.73M15.52M
Accumulated Expenses
7.41M10.05M5.69M7.57M9.15M8.70M7.26M8.74M15.16M19.45M6.57M5.76M4.72M20.33M8.57M11.41M9.78M8.79M5.90M5.96M
Other Accumulated Expenses
0.67M1.73M1.68M1.92M1.74M0.22M0.57M0.75M0.56M2.63M2.71M2.65M2.67M2.68M2.70M2.72M2.73M2.75M2.77M2.79M
Short term Debt
3.08M2.65M2.70M2.70M2.70M
Current Leases
0.69M0.74M0.77M0.68M0.60M0.46M0.31M0.43M
Current Deferred Revenue
25.80M3.77M3.89M3.89M3.91M3.92M3.94M3.97M3.98M
Total Current Liabilities
17.84M22.93M16.73M16.22M19.79M21.94M18.26M22.83M27.32M30.95M20.08M15.68M18.82M31.60M21.51M26.84M25.63M28.64M27.37M28.24M
Non-Current Liabilities
Non-Current Debt
Non-Current Deffered Revenue
21.18M20.04M19.21M18.22M17.49M16.17M15.29M14.31M
Preferred Stock Liabilities
Liabilities from Discontinued Operations
2.20M2.20M2.20M2.20M2.20M2.20M2.20M2.20M2.20M2.20M
Non-Current Deferred Tax Liability
0.37M0.37M0.37M0.37M0.37M0.37M0.37M0.37M0.37M
Other Non-Current Liabilities
26.20M28.40M27.20M23.80M26.00M33.10M32.30M30.80M32.50M6.20M9.00M9.20M10.00M8.70M9.00M10.50M10.60M11.00M11.00M11.30M
Total Non-Current Liabilities
20.71M25.47M19.13M18.42M21.79M23.88M20.59M25.10M29.52M34.03M23.05M18.05M42.24M56.07M45.03M46.91M44.83M46.38M44.07M43.81M
Total Liabilities
46.91M53.87M46.33M42.22M47.79M56.98M52.90M55.90M62.02M40.23M32.05M27.25M52.24M64.77M54.03M57.41M55.43M57.38M55.07M55.11M
Shareholder's Equity
Total Debt
3.08M2.65M2.70M2.70M2.70M
Common Equity
216.58M197.34M180.20M235.75M219.84M197.62M176.81M179.75M156.33M157.18M142.01M133.82M130.15M155.55M144.07M131.74M120.10M103.08M143.65M124.58M
Liabilities and Shareholders Equity
263.49M251.21M226.53M277.98M267.63M254.60M229.71M235.65M218.35M197.41M174.06M161.07M182.39M220.33M198.09M189.15M175.53M160.46M198.72M179.69M
Retained Earnings
789.19M792.97M795.37M871.80M875.98M880.83M887.64M920.90M926.77M928.08M930.11M933.01M936.03M1,058.32M1,061.58M1,064.63M1,067.49M1,070.26M1,131.23M1,134.00M
Treasury Shares